{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T06:11:03Z","timestamp":1788502263595,"version":"build-2803163510"},"reference-count":76,"publisher":"Oxford University Press (OUP)","issue":"12","license":[{"start":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T00:00:00Z","timestamp":1755648000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"Nation Key Research and Development Program of China","award":["2022YFC3501705"],"award-info":[{"award-number":["2022YFC3501705"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82274066"],"award-info":[{"award-number":["82274066"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Shanghai Leading Talents Program","award":["SHLJ2019100"],"award-info":[{"award-number":["SHLJ2019100"]}]},{"name":"Shanghai Science and Technology Innovation","award":["22S21901200"],"award-info":[{"award-number":["22S21901200"]}]},{"DOI":"10.13039\/501100013105","name":"Shanghai Rising-Star Program","doi-asserted-by":"publisher","award":["24YF2741000"],"award-info":[{"award-number":["24YF2741000"]}],"id":[{"id":"10.13039\/501100013105","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,11,28]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>Ling Gui Zhu Gan (LGZG) Granules is a marketed traditional Chinese medicine compound granule, which is formulated to be consistent with the key quality attributes of the traditional LGZG Decoction. The volatile components are important parts of its preparation process.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A high-fat diet (HFD)-induced Non-alcoholic fatty liver disease (NAFLD) mouse model was established to evaluate the therapeutic effects of LGZG and preparation of LGZG\u2019s volatile components (IC-LGZG). Gut microbiota composition, Short-chain Fatty Acids (SCFA) levels, and intestinal parameters were assessed, and its correlations were analyzed. Lipopolysaccharide-induced RAW264.7 cells tested anti-inflammatory effects.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Key findings<\/jats:title>\n                    <jats:p>LGZG and IC-LGZG significantly reduced HFD-induced body weight gain, improved lipid profiles and liver function, restored gut microbiota balance, increased beneficial bacteria (Akkermansia, Bacteroides, Parabacteroides, Dubosiella, and Bifidobacterium) that produce SCFAs, thereby enhancing SCFA concentrations (acetic acid, propionic acid, and butyric acid), decreased harmful bacteria abundance, and strengthened the intestinal barrier. In vitro studies showed that LGZG, IC-LGZG, and cinnamaldehyde exerted anti-inflammatory effects.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>LGZG and its volatile components effectively alleviate the progression of NAFLD by modulating the gut microbiota homeostasis and SCFA levels, and can exert anti-inflammatory effects.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/jpp\/rgaf070","type":"journal-article","created":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T11:54:23Z","timestamp":1754049263000},"page":"1676-1689","source":"Crossref","is-referenced-by-count":3,"title":["Intervention of non-alcoholic fatty liver disease by Ling Gui Zhu Gan Granules and its volatile components through the metabolism of intestinal microbiota and short-chain fatty acids"],"prefix":"10.1093","volume":"77","author":[{"given":"Nan","family":"Wang","sequence":"first","affiliation":[{"name":"School of Pharmacy, Shanghai University of Traditional Chinese Medicine , Pudong New District, No 1200, Cai lun Road, Shanghai 201203 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Li","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Shanghai University of Traditional Chinese Medicine , Pudong New District, No 1200, Cai lun Road, Shanghai 201203 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ze-Xuan","family":"Chen","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Shanghai University of Traditional Chinese Medicine , Pudong New District, No 1200, Cai lun Road, Shanghai 201203 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Tang","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Shanghai University of Traditional Chinese Medicine , Pudong New District, No 1200, Cai lun Road, Shanghai 201203 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue-Yee","family":"Lim","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Shanghai University of Traditional Chinese Medicine , Pudong New District, No 1200, Cai lun Road, Shanghai 201203 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6865-265X","authenticated-orcid":false,"given":"Ling","family":"Li","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Shanghai University of Traditional Chinese Medicine , Pudong New District, No 1200, Cai lun Road, Shanghai 201203 ,","place":["China"]},{"name":"College of Pharmacy, Anhui University of Traditional Chinese Medicine , Yaohai District, No 350, Long zi hu Road, Hefei 230000 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Zhang","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Shanghai University of Traditional Chinese Medicine , Pudong New District, No 1200, Cai lun Road, Shanghai 201203 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,8,20]]},"reference":[{"key":"2025120200422399200_ref1","doi-asserted-by":"publisher","first-page":"101833","DOI":"10.1016\/j.jsps.2023.101833","article-title":"A preparation technology of volatile components in Linggui Zhugan decoction based on the transfer of cinnamaldehyde and its anti-gastric ulcer effect","volume":"31","author":"Li","year":"2023","journal-title":"Saudi Pharm J"},{"key":"2025120200422399200_ref2","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1016\/S0140-6736(20)32511-3","article-title":"Non-alcoholic fatty liver disease","volume":"397","author":"Powell","year":"2021","journal-title":"Lancet"},{"key":"2025120200422399200_ref3","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s12906-018-2424-1","article-title":"The traditional Chinese formulae Ling-gui-zhu-Gan decoction alleviated non-alcoholic fatty liver disease via inhibiting PPP1R3C mediated molecules","volume":"19","author":"Dang","year":"2019","journal-title":"Bmc Complem Altern M"},{"key":"2025120200422399200_ref4","doi-asserted-by":"publisher","first-page":"109976","DOI":"10.1016\/j.biopha.2020.109976","article-title":"Ling-gui-zhu-Gan decoction alleviates hepatic steatosis through SOCS2 modification by N6-methyladenosine","volume":"127","author":"Dang","year":"2020","journal-title":"Biomed Pharmacother"},{"key":"2025120200422399200_ref5","volume-title":"Lingguizhugan Decoction for Non-alcoholic Fatty Liver Diseasewith Spleen-Yang Deficiency Pattern: A Study Based on\u201cFormula-to-Pattern\u201d Effect","author":"Xu","year":"2020"},{"key":"2025120200422399200_ref6","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s13020-021-00559-3","article-title":"Traditional Chinese medicine Lingguizhugan decoction ameliorate HFD-induced hepatic-lipid deposition in mice by inhibiting STING-mediated inflammation in macrophages","volume":"17","author":"Cao","year":"2022","journal-title":"Chin Med"},{"key":"2025120200422399200_ref7","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.875549","article-title":"Theabrownin and Poria cocos polysaccharide improve lipid metabolism via modulation of bile acid and fatty acid metabolism\u2014PubMed","volume":"13","author":"Wang","year":"2022","journal-title":"Front Pharmacol"},{"key":"2025120200422399200_ref8","doi-asserted-by":"publisher","first-page":"115457","DOI":"10.1016\/j.jep.2022.115457","article-title":"Poria cocos polysaccharides rescue pyroptosis-driven gut vascular barrier disruption in order to alleviates non-alcoholic steatohepatitis","volume":"296","author":"Ye","year":"2022","journal-title":"J Ethnopharmacol"},{"key":"2025120200422399200_ref9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2021\/9561613","article-title":"Cinnamic acid ameliorates nonalcoholic fatty liver disease by suppressing hepatic lipogenesis and promoting fatty acid oxidation","volume":"2021","author":"Wu","year":"2021","journal-title":"Evid-Based Complement Altern Med"},{"key":"2025120200422399200_ref10","first-page":"5747","article-title":"Unraveling the mechanisms of trans-cinnamic acid in ameliorating non-alcoholic fatty liver disease","volume":"9","author":"Solanki","year":"2023","journal-title":"Am J Transl Res"},{"key":"2025120200422399200_ref11","doi-asserted-by":"publisher","first-page":"113014","DOI":"10.1016\/j.intimp.2024.113014","article-title":"Polysaccharide of Atractylodes macrocephala Koidz alleviates NAFLD-induced hepatic inflammation in mice by modulating the TLR4\/MyD88\/NF-\u03baB pathway","volume":"141","author":"Chen","year":"2024","journal-title":"Int Immunopharmacol"},{"key":"2025120200422399200_ref12","doi-asserted-by":"publisher","first-page":"106201","DOI":"10.1016\/j.jff.2024.106201","article-title":"Identification of key genes involved in the alleviative effects of polysaccharide of Atractylodes macrocephala Koidz on high-fat diet-induced nonalcoholic fatty liver disease in mice","volume":"116","author":"Chen","year":"2024","journal-title":"J Funct Foods"},{"key":"2025120200422399200_ref13","doi-asserted-by":"publisher","first-page":"121110","DOI":"10.1016\/j.lfs.2022.121110","article-title":"Modulation of gut microbiota by glycyrrhizic acid may contribute to its anti-NAFLD effect in rats fed a high-fat diet","volume":"310","author":"Wang","year":"2022","journal-title":"Life Sci"},{"key":"2025120200422399200_ref14","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.phrs.2017.05.019","article-title":"Cinnamaldehyde in diabetes: a review of pharmacology, pharmacokinetics and safety","volume":"122","author":"Zhu","year":"2017","journal-title":"Pharmacol Res"},{"key":"2025120200422399200_ref15","doi-asserted-by":"publisher","first-page":"779608","DOI":"10.3389\/fphar.2022.779608","article-title":"Cinnamaldehyde suppressed EGF-induced EMT process and inhibits ovarian cancer progression through PI3K\/AKT pathway","volume":"13","author":"Wang","year":"2022","journal-title":"Front Pharmacol"},{"key":"2025120200422399200_ref16","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1080\/0886022x.2022.2056485","article-title":"Cinnamaldehyde attenuates kidney senescence and injury through PI3K\/Akt pathway-mediated autophagy via downregulating miR-155","volume":"44","author":"Xiao","year":"2022","journal-title":"Ren Fail"},{"key":"2025120200422399200_ref17","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1002\/biof.1265","article-title":"Cinnamaldehyde supplementation prevents fasting-induced hyperphagia, lipid accumulation, and inflammation in high-fat diet-fed mice","volume":"42","author":"Khare","year":"2016","journal-title":"BioFactors"},{"key":"2025120200422399200_ref18","doi-asserted-by":"publisher","first-page":"5820","DOI":"10.3390\/ijms21165820","article-title":"Gut-pancreas-liver Axis as a target for treatment of NAFLD\/NASH","volume":"21","author":"Svegliati-Baroni","year":"2020","journal-title":"Int J Mol Sci"},{"key":"2025120200422399200_ref19","doi-asserted-by":"publisher","first-page":"e1800930","DOI":"10.1002\/mnfr.201800930","article-title":"Functional interactions between gut microbiota transplantation, quercetin, and high-fat diet determine non-alcoholic fatty liver disease development in germ-free mice","volume":"63","author":"Porras","year":"2019","journal-title":"Mol Nutr Food Res"},{"key":"2025120200422399200_ref20","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1136\/gutjnl-2012-303816","article-title":"Intestinal microbiota determines development of non-alcoholic fatty liver disease in mice","volume":"62","author":"Le Roy","year":"2013","journal-title":"Gut"},{"key":"2025120200422399200_ref21","doi-asserted-by":"publisher","first-page":"1066053","DOI":"10.3389\/fcimb.2023.1066053","article-title":"Lingguizhugan decoction improves non-alcoholic steatohepatitis partially by modulating gut microbiota and correlated metabolites","volume":"13","author":"Zhu","year":"2023","journal-title":"Front Cell Infect Microbiol"},{"key":"2025120200422399200_ref22","doi-asserted-by":"publisher","first-page":"e0197923","DOI":"10.1128\/spectrum.01979-23","article-title":"Ling-Gui-Zhu-Gan decoction ameliorates nonalcoholic fatty liver disease via modulating the gut microbiota","volume":"12","author":"Chen","year":"2024","journal-title":"Microbiol Spectr"},{"key":"2025120200422399200_ref23","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/1476-511X-10-23","article-title":"Comparison of dietary control and atorvastatin on high fat diet induced hepatic steatosis and hyperlipidemia in rats","volume":"10","author":"Ji","year":"2011","journal-title":"Lipids Health Dis"},{"key":"2025120200422399200_ref24","doi-asserted-by":"publisher","first-page":"1174742","DOI":"10.3389\/fphar.2023.1174742","article-title":"Comparison of pharmacokinetic profiles of seven major bioactive components in normal and non-alcoholic fatty liver disease (NAFLD) rats after oral administration of Ling-Gui-Zhu-Gan decoction by UPLC-MS\/MS","volume":"14","author":"Nie","year":"2023","journal-title":"Front Pharmacol"},{"key":"2025120200422399200_ref25","first-page":"361","article-title":"Inhibition of cinnamic aldehyde on migration and M1 polarization of Raw264.7 macrophages induced by LPS. Traditional Chinese drug research and clinical","volume":"03","author":"Jiang","year":"2016","journal-title":"Pharmacology"},{"key":"2025120200422399200_ref26","doi-asserted-by":"publisher","first-page":"3009","DOI":"10.3748\/wjg.v25.i24.3009","article-title":"Biomarkers and subtypes of deranged lipid metabolism in non-alcoholic fatty liver disease","volume":"25","author":"Mato","year":"2019","journal-title":"World J Gastroenterol"},{"key":"2025120200422399200_ref27","doi-asserted-by":"publisher","first-page":"15791","DOI":"10.3390\/ijms232415791","article-title":"Genetic and diet-induced animal models for non-alcoholic fatty liver disease (NAFLD) research","volume":"23","author":"Flessa","year":"2022","journal-title":"Int J Mol Sci"},{"key":"2025120200422399200_ref28","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/S1499-3872(17)60019-5","article-title":"Gut microbiota dysbiosis in patients with non-alcoholic fatty liver disease","volume":"16","author":"Shen","year":"2017","journal-title":"Hepatob Pancreat Dis"},{"key":"2025120200422399200_ref29","doi-asserted-by":"publisher","first-page":"5976","DOI":"10.1039\/d0fo00795a","article-title":"Ameliorative effects and molecular mechanisms of vine tea on western diet-induced NAFLD","volume":"11","author":"Xie","year":"2020","journal-title":"Food Funct"},{"key":"2025120200422399200_ref30","doi-asserted-by":"publisher","first-page":"4704771","DOI":"10.1155\/2021\/4704771","article-title":"Dietary valine ameliorated gut health and accelerated the development of nonalcoholic fatty liver disease of laying hens","volume":"2021","author":"Jian","year":"2021","journal-title":"Oxidative Med Cell Longev"},{"key":"2025120200422399200_ref31","doi-asserted-by":"publisher","first-page":"e634","DOI":"10.1002\/ctm2.634","article-title":"Lactobacillus lactis and Pediococcus pentosaceus-driven reprogramming of gut microbiome and metabolome ameliorates the progression of non-alcoholic fatty liver disease","volume":"11","author":"Yu","year":"2021","journal-title":"Clin Transl Med"},{"key":"2025120200422399200_ref32","doi-asserted-by":"publisher","first-page":"1072133","DOI":"10.3389\/fnut.2022.1072133","article-title":"Modulatory effect of camel milk on intestinal microbiota of mice with non-alcoholic fatty liver disease","volume":"9","author":"Hao","year":"2022","journal-title":"Front Nutr"},{"key":"2025120200422399200_ref33","doi-asserted-by":"publisher","first-page":"111732","DOI":"10.1016\/j.foodres.2022.111732","article-title":"Noni (Morinda citrifolia L.) fruit phenolic extract supplementation ameliorates NAFLD by modulating insulin resistance, oxidative stress, inflammation, liver metabolism and gut microbiota","volume":"160","author":"Wang","year":"2022","journal-title":"Food Res Int"},{"key":"2025120200422399200_ref34","doi-asserted-by":"publisher","first-page":"916089","DOI":"10.3389\/fmicb.2022.916089","article-title":"High-fat diet-induced intestinal dysbiosis is associated with the exacerbation of Sjogren's syndrome","volume":"13","author":"Zhang","year":"2022","journal-title":"Front Microbiol"},{"key":"2025120200422399200_ref35","doi-asserted-by":"publisher","first-page":"1121203","DOI":"10.3389\/fnut.2023.1121203","article-title":"Effects of cholesterol-lowering probiotics on non-alcoholic fatty liver disease in FXR gene knockout mice","volume":"10","author":"Yang","year":"2023","journal-title":"Front Nutr"},{"key":"2025120200422399200_ref36","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1002\/hep.31178","article-title":"Fecal microbiome distinguishes alcohol consumption from alcoholic hepatitis but does not discriminate disease severity","volume":"72","author":"Smirnova","year":"2020","journal-title":"Hepatology"},{"key":"2025120200422399200_ref37","doi-asserted-by":"publisher","first-page":"5982","DOI":"10.1021\/jf900470c","article-title":"Acetic acid upregulates the expression of genes for fatty acid oxidation enzymes in liver to suppress body fat accumulation","volume":"57","author":"Kondo","year":"2009","journal-title":"J Agr Food Chem"},{"key":"2025120200422399200_ref38","doi-asserted-by":"publisher","first-page":"2398","DOI":"10.2337\/db14-1213","article-title":"Short-chain fatty acids protect against high-fat diet-induced obesity via a PPAR\u03b3-dependent switch from lipogenesis to fat oxidation","volume":"64","author":"Den Besten","year":"2015","journal-title":"Diabetes"},{"key":"2025120200422399200_ref39","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1038\/ijo.2016.23","article-title":"Reprogramming of hepatic fat accumulation and 'browning' of adipose tissue by the short-chain fatty acid acetate","volume":"40","author":"Sahuri-Arisoylu","year":"2016","journal-title":"Int J Obesity"},{"key":"2025120200422399200_ref40","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.2337\/db16-0924","article-title":"Butyrate regulates liver mitochondrial function, efficiency, and dynamics in insulin-resistant obese mice","volume":"66","author":"Mollica","year":"2017","journal-title":"Diabetes"},{"key":"2025120200422399200_ref41","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/s41574-019-0156-z","article-title":"Gut microbial metabolites in obesity, NAFLD and T2DM","volume":"15","author":"Canfora","year":"2019","journal-title":"Nat Rev Endocrinol"},{"key":"2025120200422399200_ref42","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1016\/j.chom.2015.03.005","article-title":"Crosstalk between microbiota-derived short-chain fatty acids and intestinal epithelial HIF augments tissue barrier function","volume":"17","author":"Kelly","year":"2015","journal-title":"Cell Host Microbe"},{"key":"2025120200422399200_ref43","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1038\/nature08530","article-title":"Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43","volume":"461","author":"Maslowski","year":"2009","journal-title":"Nature"},{"key":"2025120200422399200_ref44","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/nature10809","article-title":"Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity","volume":"482","author":"Henao-Mejia","year":"2012","journal-title":"Nature"},{"key":"2025120200422399200_ref45","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.3390\/nu12041107","article-title":"The effect of probiotics on the production of short-chain fatty acids by human intestinal microbiome","volume":"12","author":"Markowiak-Kopec","year":"2020","journal-title":"Nutrients"},{"key":"2025120200422399200_ref46","doi-asserted-by":"publisher","first-page":"762691","DOI":"10.3389\/fendo.2021.762691","article-title":"Chlorogenic acid-induced gut microbiota improves metabolic endotoxemia","volume":"12","author":"Ye","year":"2021","journal-title":"Front Endocrinol"},{"key":"2025120200422399200_ref47","doi-asserted-by":"publisher","first-page":"2500","DOI":"10.19540\/j.cnki.cjcmm.20211208.401","article-title":"Gynostemma pentaphyllum saponins alleviate non-alcoholic fatty liver disease in rats by regulating intestinal flora and short-chain fatty acid metabolism","volume":"9","author":"Zhong","year":"2022","journal-title":"China J Chin Mater Med"},{"key":"2025120200422399200_ref48","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1080\/09637486.2023.2240037","article-title":"Low-no-calorie sweeteners exert marked compound-specific impact on the human gut microbiota ex vivo","volume":"74","author":"Van Den Abbeele","year":"2023","journal-title":"Int J Food Sci Nutr"},{"key":"2025120200422399200_ref49","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.3390\/antiox10122001","article-title":"The Synbiotic combination of and quercetin ameliorates early obesity and NAFLD through gut microbiota reshaping and bile acid metabolism modulation","volume":"10","author":"Juarez-Fernandez","year":"2021","journal-title":"Antioxidants-Basel"},{"key":"2025120200422399200_ref50","doi-asserted-by":"publisher","volume":"11","journal-title":"Front Microbiol","DOI":"10.3389\/fmicb.2020.00219"},{"key":"2025120200422399200_ref51","doi-asserted-by":"publisher","first-page":"e41079","DOI":"10.1371\/journal.pone.0041079","article-title":"Bacteroides uniformis CECT 7771 ameliorates metabolic and immunological dysfunction in mice with high-fat-diet induced obesity","volume":"7","author":"Cano","year":"2012","journal-title":"PLoS One"},{"key":"2025120200422399200_ref52","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1038\/s41564-023-01418-7","article-title":"Parabacteroides distasonis uses dietary inulin to suppress NASH via its metabolite pentadecanoic acid","volume":"8","author":"Wei","year":"2023","journal-title":"Nat Microbiol"},{"key":"2025120200422399200_ref53","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1038\/s41565-023-01346-x","article-title":"Artificial-enzymes-armed Bifidobacterium longum probiotics for alleviating intestinal inflammation and microbiota dysbiosis","volume":"18","author":"Cao","year":"2023","journal-title":"Nat Nanotechnol"},{"key":"2025120200422399200_ref54","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1079\/Pns2002207","article-title":"Regulation of short-chain fatty acid production","volume":"62","author":"Macfarlane","year":"2003","journal-title":"P Nutr Soc"},{"key":"2025120200422399200_ref55","doi-asserted-by":"publisher","first-page":"8096","DOI":"10.1038\/srep08096","article-title":"Dysbiosis gut microbiota associated with inflammation and impaired mucosal immune function in intestine of humans with non-alcoholic fatty liver disease","volume":"5","author":"Jiang","year":"2015","journal-title":"Sci Rep"},{"key":"2025120200422399200_ref56","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1002\/hep.28572","article-title":"Gut microbiota profiling of pediatric nonalcoholic fatty liver disease and obese patients unveiled by an integrated meta-omics-based approach","volume":"65","author":"Del Chierico","year":"2017","journal-title":"Hepatology"},{"key":"2025120200422399200_ref57","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1038\/s41586-019-1742-x","article-title":"Bacteriophage targeting of gut bacterium attenuates alcoholic liver disease","volume":"575","author":"Duan","year":"2019","journal-title":"Nature"},{"key":"2025120200422399200_ref58","doi-asserted-by":"publisher","first-page":"118457","DOI":"10.1016\/j.lfs.2020.118457","article-title":"Liraglutide modulates gut microbiome and attenuates nonalcoholic fatty liver in db\/db mice","volume":"261","author":"Liu","year":"2020","journal-title":"Life Sci"},{"key":"2025120200422399200_ref59","doi-asserted-by":"publisher","first-page":"870785","DOI":"10.3389\/fcimb.2022.870785","article-title":"The microbiota and It's correlation with metabolites in the gut of mice with nonalcoholic fatty liver disease","volume":"12","author":"Gu","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"key":"2025120200422399200_ref60","doi-asserted-by":"publisher","first-page":"3033","DOI":"10.3390\/nu15133033","article-title":"Protective effects of white kidney bean (Phaseolus vulgaris L.) against diet-induced hepatic steatosis in mice are linked to modification of gut microbiota and its metabolites","volume":"15","author":"Feng","year":"2023","journal-title":"Nutrients"},{"key":"2025120200422399200_ref61","doi-asserted-by":"publisher","first-page":"176113","DOI":"10.1016\/j.ejphar.2023.176113","article-title":"GW9662 ameliorates nonalcoholic steatohepatitis by inhibiting the PPARgamma\/CD36 pathway and altering the gut microbiota","volume":"960","author":"Xiao","year":"2023","journal-title":"Eur J Pharmacol"},{"key":"2025120200422399200_ref62","doi-asserted-by":"publisher","first-page":"16733","DOI":"10.3390\/ijms242316733","article-title":"A high-fat diet increases the characteristics of gut microbial composition and the intestinal damage associated with non-alcoholic fatty liver disease","volume":"24","author":"Zhu","year":"2023","journal-title":"Int J Mol Sci"},{"key":"2025120200422399200_ref63","doi-asserted-by":"publisher","first-page":"e0100623","DOI":"10.1128\/spectrum.01006-23","article-title":"Role of intestinal flora in the development of nonalcoholic fatty liver disease in children","volume":"12","author":"Zhang","year":"2024","journal-title":"Microbiol Spectr"},{"key":"2025120200422399200_ref64","doi-asserted-by":"publisher","first-page":"13424","DOI":"10.1038\/s41598-019-49462-w","article-title":"Discrepant gut microbiota markers for the classification of obesity-related metabolic abnormalities","volume":"9","author":"Zeng","year":"2019","journal-title":"Sci Rep"},{"key":"2025120200422399200_ref65","doi-asserted-by":"publisher","first-page":"116692","DOI":"10.1016\/j.ecoenv.2024.116692","article-title":"Viola yedoensis Makino alleviates lipopolysaccharide-induced intestinal oxidative stress and inflammatory response by regulating the gut microbiota and NF-kappaB-NLRP3\/ Nrf2-MAPK signaling pathway in broiler","volume":"282","author":"Zhao","year":"2024","journal-title":"Ecotoxicol Environ Saf"},{"key":"2025120200422399200_ref66","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/s41575-018-0009-6","article-title":"Triggering and resolution of inflammation in NASH","volume":"15","author":"Schuster","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"2025120200422399200_ref67","doi-asserted-by":"publisher","first-page":"3306","DOI":"10.3390\/cells10123306","article-title":"Exercise-induced irisin decreases inflammation and improves NAFLD by competitive binding with MD2","volume":"10","author":"Zhu","year":"2021","journal-title":"Cells"},{"key":"2025120200422399200_ref68","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1002\/hep.32778","article-title":"Nicotinamide riboside and pterostilbene reduces markers of hepatic inflammation in NAFLD: a double-blind, placebo-controlled clinical trial","volume":"78","author":"Dellinger","year":"2023","journal-title":"Hepatology"},{"key":"2025120200422399200_ref69","doi-asserted-by":"publisher","first-page":"6635","DOI":"10.1038\/s41467-023-42420-1","article-title":"RING finger protein 13 protects against nonalcoholic steatohepatitis by targeting STING-relayed signaling pathways","volume":"14","author":"Lin","year":"2023","journal-title":"Nat Commun"},{"key":"2025120200422399200_ref70","doi-asserted-by":"publisher","first-page":"827","DOI":"10.3892\/mmr.2017.7983","article-title":"Effect of Linguizhugan decoction on neuroinflammation and expression disorder of the amyloid beta-related transporters RAGE and LRP-1 in a rat model of Alzheimer's disease","volume":"17","author":"Hu","year":"2018","journal-title":"Mol Med Rep"},{"key":"2025120200422399200_ref71","doi-asserted-by":"publisher","first-page":"155942","DOI":"10.1016\/j.phymed.2024.155942","article-title":"Lingguizhugan decoction ameliorates cognitive impairment in AD-like mice by influencing the microbiome-gut-brain axis mediated by SCFAs","volume":"133","author":"Du","year":"2024","journal-title":"Phytomedicine"},{"key":"2025120200422399200_ref72","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2017\/2790864","article-title":"Lingguizhugan decoction protects against high-fat-diet-induced nonalcoholic fatty liver disease by alleviating oxidative stress and activating cholesterol secretion. Int","volume":"2017","author":"Yang","year":"2017","journal-title":"J Genomics"},{"key":"2025120200422399200_ref73","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.ejphar.2018.05.003","article-title":"Pro- and anti-inflammatory effects of short chain fatty acids on immune and endothelial cells","volume":"831","author":"Li","year":"2018","journal-title":"Eur J Pharmacol"},{"key":"2025120200422399200_ref74","doi-asserted-by":"publisher","first-page":"2848","DOI":"10.1097\/01.MIB.0000435444.14860.ea","article-title":"G protein-coupled receptor 43 moderates gut inflammation through cytokine regulation from mononuclear cells","volume":"19","author":"Masui","year":"2013","journal-title":"Inflamm Bowel Dis"},{"key":"2025120200422399200_ref75","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.nut.2009.07.006","article-title":"Butyrate and propionate induced activated or non-activated neutrophil apoptosis via HDAC inhibitor activity but without activating GPR-41\/GPR-43 pathways","volume":"26","author":"Aoyama","year":"2010","journal-title":"Nutrition"},{"key":"2025120200422399200_ref76","doi-asserted-by":"publisher","first-page":"6356","DOI":"10.3390\/ijms21176356","article-title":"Short-chain fatty acids and their association with signalling pathways in inflammation, glucose and lipid metabolism","volume":"21","author":"He","year":"2020","journal-title":"Int J Mol Sci"}],"container-title":["Journal of Pharmacy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jpp\/article-pdf\/77\/12\/1676\/64096228\/rgaf070.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jpp\/article-pdf\/77\/12\/1676\/64096228\/rgaf070.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T05:42:29Z","timestamp":1764654149000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jpp\/article\/77\/12\/1676\/8238763"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,20]]},"references-count":76,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2025,8,20]]},"published-print":{"date-parts":[[2025,11,28]]}},"URL":"https:\/\/doi.org\/10.1093\/jpp\/rgaf070","relation":{},"ISSN":["0022-3573","2042-7158"],"issn-type":[{"value":"0022-3573","type":"print"},{"value":"2042-7158","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,12]]},"published":{"date-parts":[[2025,8,20]]}}}